首页 | 本学科首页   官方微博 | 高级检索  
   检索      


A non-catalytic function of the Src family tyrosine kinases controls prolactin-induced Jak2 signaling
Authors:José Manuel García-Martínez  Annarica Calcabrini  Lorena González  Esther Martín-Forero  María Teresa Agulló-Ortuño  Valérie Simon  Harriet Watkin  Steve M Anderson  Serge Roche  Jorge Martín-Pérez
Institution:1. Instituto de Investigaciones Biomédicas A. Sols (CSIC/UAM), Arturo Duperier 4, 28029 Madrid, Spain;2. Department of Pathology and Program in Molecular Biology, University of Colorado Health Sciences Center, Research Complex I, South Tower, 12801 East 17th Avenue, Aurora, CO 80045, USA;3. CNRS UMR5237 UM1 & 2,CRBM, 1919 route de Mende, 34000 Montpellier, France;1. Department of Pharmacology, Case Western Reserve University School of Medicine, Case Comprehensive Cancer Center, and University Hospitals Case Medical Center, Cleveland, OH 44106, USA;2. Department of Medicine, Case Western Reserve University School of Medicine, Case Comprehensive Cancer Center, and University Hospitals Case Medical Center, Cleveland, OH 44106, USA;3. Department of Medicine, University of California, San Diego, La Jolla, California 92093-0726;4. Department of Biochemistry, University of Leicester, Leicester LE1 9HN, United Kingdom
Abstract:The cytokine prolactin (PRL) plays important roles in the proliferation and differentiation of the mammary gland and it has been implicated in tumorigenesis. The prolactin receptor (PRLR) is devoid of catalytic activity and its mitogenic response is controlled by cytoplasmic tyrosine kinases of the Src (SFK) and Jak families. How PRLR uses these kinases for signaling is not well understood. Previous studies indicated that PRLR-induced Jak2 activation does not require SFK catalytic activity in favor of separate signaling operating on this cellular response. Here we show that, nevertheless, PRLR requires Src-SH2 and -SH3 domains for Jak2 signaling. In W53 lymphoid cells, conditional expression of two c-Src non-catalytic mutants, either SrcK295M/Y527F or Src?K, whose SH3 and SH2 domains are exposed, controls Jak2/Stat5 activation by recruiting Jak2, avoiding its activation by endogenous active SFK. In contrast, the kinase inactive SrcK295M mutant, with inaccessible SH3 and SH2 domains, does not. Furthermore, all three mutants attenuate PRLR-induced Akt and p70S6K activation. Accordingly, PRLR-induced Jak2/Stat5 signaling is inhibited in MCF7 breast cancer cells by Src depletion, expression of SrcK295M/Y527F or active Src harboring an inactive SH2 (SrcR175L) or SH3 domain (SrcW118A). Finally, Jak2/Stat5 pathway is also reduced in Src?/? mice mammary glands. We thus conclude that, in addition to Akt and p70S6K, SFK regulate PRLR-induced Jak2 signaling through a kinase-independent mechanism.
Keywords:
本文献已被 ScienceDirect 等数据库收录!
设为首页 | 免责声明 | 关于勤云 | 加入收藏

Copyright©北京勤云科技发展有限公司  京ICP备09084417号